-
1
-
-
79952717349
-
ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis . An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management
-
Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management . Am J Respir Crit Care Med . 2011; 183 (6) : 788 - 824 .
-
(2011)
Am J Respir Crit Care Med.
, vol.183
, Issue.6
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
-
2
-
-
20944434994
-
Double-blind, placebocontrolled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
. Azuma A, Nukiwa T, Tsuboi E, et al . Double-blind, placebocontrolled trial of pirfenidone in patients with idiopathic pulmonary fibrosis . Am J Respir Crit Care Med . 2005; 171 (9) : 1040 - 1047 .
-
(2005)
Am J Respir Crit Care Med
, vol.171
, Issue.9
, pp. 1040-1047
-
-
Azuma, A.1
Nukiwa, T.2
Tsuboi, E.3
-
3
-
-
28144459814
-
Ifigenia study group . High-dose acetylcysteine in idiopathic pulmonary fibrosis
-
Demedts M, Behr J, Buhl R, et al; IFIGENIA Study Group . High-dose acetylcysteine in idiopathic pulmonary fibrosis . N Engl J Med . 2005; 353 (21) : 2229 - 2242
-
(2005)
N Engl J Med.
, vol.353
, Issue.21
, pp. 2229-2242
-
-
Demedts, M.1
Behr, J.2
Buhl, R.3
-
4
-
-
67650349068
-
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (inspire): A multicentre,randomised, placebo-controlled trial
-
INSPIRE Study Group
-
King TE Jr, Albera C, Bradford WZ, et al ; INSPIRE Study Group . Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre,= randomised, placebo-controlled trial . Lancet . 2009; 374 (9685): 222 - 228 .
-
(2009)
Lancet.
, vol.374
, Issue.9685
, pp. 222-228
-
-
King, Jr.T.E.1
Albera, C.2
Bradford, W.Z.3
-
5
-
-
37849012578
-
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
-
. King TE Jr, Behr J, Brown KK, et al . BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis . Am J Respir Crit Care Med . 2008; 177 (1) : 75 - 81 .
-
(2008)
Am J Respir Crit Care Med
, vol.177
, Issue.1
, pp. 75-81
-
-
King, Jr.T.E.1
Behr, J.2
Brown, K.K.3
-
6
-
-
80051566676
-
BUILD-3: A randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis
-
. King TE Jr, Brown KK, Raghu G, et al . BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis . Am J Respir Crit Care Med . 2011; 184 (1) : 92 - 99 .
-
(2011)
Am J Respir Crit Care Med
, vol.184
, Issue.1
, pp. 92-99
-
-
King, Jr.T.E.1
Brown, K.K.2
Raghu, G.3
-
7
-
-
79956341531
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials
-
CAPACITY Study Group
-
Noble PW, Albera C, Bradford WZ, et al; CAPACITY Study Group . Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials . Lancet . 2011; 377 (9779) : 1760 - 1769 .
-
(2011)
Lancet.
, vol.377
, Issue.9779
, pp. 1760-1769
-
-
Noble, P.W.1
Albera, C.2
Bradford, W.Z.3
-
8
-
-
0345824715
-
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
-
Idiopathic Pulmonary Fibrosis Study Group
-
Raghu G, Brown KK, Bradford WZ, et al; Idiopathic Pulmonary Fibrosis Study Group . A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis . N Engl J Med . 2004; 350 (2) : 125 - 133 .
-
(2004)
N Engl J Med .
, vol.350
, Issue.2
, pp. 125-133
-
-
Raghu, G.1
Brown, K.K.2
Bradford, W.Z.3
-
9
-
-
55549147184
-
Treatment of idiopathic pulmonary fibrosis with etanercept: An exploratory, placebocontrolled trial
-
Raghu G, Brown KK, Costabel U, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebocontrolled trial . Am J Respir Crit Care Med . 2008; 178 (9) :948 - 955 .
-
(2008)
Am J Respir Crit Care Med
, vol.178
, Issue.9
, pp. 948-955
-
-
Raghu, G.1
Brown, K.K.2
Costabel, U.3
-
10
-
-
0032926937
-
Treatment of idiopathic pulmonary fibrosis with a new antifi brotic agent, pirfenidone: Results of a prospective, open-label phase II study
-
Raghu G, Johnson WC, Lockhart D, Mageto Y . Treatment of idiopathic pulmonary fibrosis with a new antifi brotic agent, pirfenidone: results of a prospective, open-label phase II study . Am J Respir Crit Care Med . 1999; 159 (4 pt 1) : 1061 - 1069 .
-
(1999)
Am J Respir Crit Care Med
, vol.159
, Issue.4 PART 1
, pp. 1061-1069
-
-
Raghu, G.1
Johnson, W.C.2
Lockhart, D.3
Mageto, Y.4
-
11
-
-
77951160564
-
Pirfenidone in idiopathic pulmonary fibrosis
-
Taniguchi H, Ebina M, Kondoh Y, et al . Pirfenidone in idiopathic pulmonary fibrosis . Eur Respir J . 2010; 35 (4) : 821 - 829 .
-
(2010)
Eur Respir J
, vol.35
, Issue.4
, pp. 821-829
-
-
Taniguchi, H.1
Ebina, M.2
Kondoh, Y.3
-
12
-
-
77956640423
-
A controlled trial of sildenafi l in advanced idiopathic pulmonary fibrosis
-
Idiopathic Pulmonary Fibrosis Clinical Research Network
-
Idiopathic Pulmonary Fibrosis Clinical Research Network; Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW. A controlled trial of sildenafi l in advanced idiopathic pulmonary fibrosis . N Engl J Med . 2010; 363 (7) : 620 - 628 .
-
(2010)
N Engl J Med .
, vol.363
, Issue.7
, pp. 620-628
-
-
Zisman, D.A.1
Schwarz, M.2
Anstrom, K.J.3
Collard, H.R.4
Flaherty, K.R.5
Hunninghake, G.W.6
-
13
-
-
63349091740
-
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis
-
. Fell CD, Liu LX, Motika C, et al . The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis . Am J Respir Crit Care Med . 2009; 179 (5) : 402 - 407 .
-
(2009)
Am J Respir Crit Care Med
, vol.179
, Issue.5
, pp. 402-407
-
-
Fell, C.D.1
Liu, L.X.2
Motika, C.3
-
14
-
-
0037312730
-
Radiological versus histological diagnosis in UIP and NSIP: Survival implications
-
. Flaherty KR, Thwaite EL, Kazerooni EA, et al . Radiological versus histological diagnosis in UIP and NSIP: survival implications . Thorax . 2003; 58 (2) : 143 - 148 .
-
(2003)
Thorax
, vol.58
, Issue.2
, pp. 143-148
-
-
Flaherty, K.R.1
Thwaite, E.L.2
Kazerooni, E.A.3
-
15
-
-
18244383070
-
Clinical signifi - Cance of histological classification of idiopathic interstitial pneumonia
-
. Flaherty KR, Toews GB, Travis WD, et al . Clinical signifi - cance of histological classification of idiopathic interstitial pneumonia . Eur Respir J . 2002; 19 (2) : 275 - 283 .
-
(2002)
Eur Respir J
, vol.19
, Issue.2
, pp. 275-283
-
-
Flaherty, K.R.1
Toews, G.B.2
Travis, W.D.3
-
16
-
-
13844316832
-
Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis
-
. King TE Jr, Safrin S, Starko KM, et al . Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis . Chest . 2005; 127 (1) : 171 - 177 .
-
(2005)
Chest
, vol.127
, Issue.1
, pp. 171-177
-
-
King, Jr.T.E.1
Safrin, S.2
Starko, K.M.3
-
17
-
-
10744229010
-
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia
-
Lama VN, Flaherty KR, Toews GB, et al . Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia . Am J Respir Crit Care Med . 2003; 168 (9) : 1084 - 1090 .
-
(2003)
Am J Respir Crit Care Med
, vol.168
, Issue.9
, pp. 1084-1090
-
-
Lama, V.N.1
Flaherty, K.R.2
Toews, G.B.3
-
18
-
-
0041874992
-
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis
-
Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK . Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis . Am J Respir Crit Care Med . 2003; 168 (5) : 538 - 542 .
-
(2003)
Am J Respir Crit Care Med
, vol.168
, Issue.5
, pp. 538-542
-
-
Collard, H.R.1
King Jr., T.E.2
Bartelson, B.B.3
Vourlekis, J.S.4
Schwarz, M.I.5
Brown, K.K.6
-
19
-
-
0041374153
-
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia
-
Flaherty KR, Mumford JA, Murray S, et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia . Am J Respir Crit Care Med . 2003; 168 (5) : 543 - 548 .
-
(2003)
Am J Respir Crit Care Med
, vol.168
, Issue.5
, pp. 543-548
-
-
Flaherty, K.R.1
Mumford, J.A.2
Murray, S.3
-
20
-
-
0041374155
-
Fibrotic idiopathic interstitial pneumonia: The prognostic value of longitudinal functional trends
-
Latsi PI, du Bois RM, Nicholson AG, et al . Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends . Am J Respir Crit Care Med . 2003; 168 (5) : 531 - 537 .
-
(2003)
Am J Respir Crit Care Med
, vol.168
, Issue.5
, pp. 531-537
-
-
Latsi, P.I.1
Du Bois, R.M.2
Nicholson, A.G.3
-
21
-
-
20144381640
-
Physiology is a stronger predictor of survival than pathology in fi brotic interstitial pneumonia
-
Jegal Y, Kim DS, Shim TS, et al. Physiology is a stronger predictor of survival than pathology in fi brotic interstitial pneumonia . Am J Respir Crit Care Med . 2005; 171 (6) : 639 - 644 .
-
(2005)
Am J Respir Crit Care Med
, vol.171
, Issue.6
, pp. 639-644
-
-
Jegal, Y.1
Kim, D.S.2
Shim, T.S.3
-
22
-
-
80051819865
-
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis
-
du Bois RM, Weycker D, Albera C, et al . Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis . Am J Respir Crit Care Med . 2011; 184 (4) :459 - 466 .
-
(2011)
Am J Respir Crit Care Med
, vol.184
, Issue.4
, pp. 459-466
-
-
Du Bois, R.M.1
Weycker, D.2
Albera, C.3
-
23
-
-
84862826491
-
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
-
Richeldi L, Ryerson CJ, Lee JS, et al . Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis . Thorax . 2012; 67 (5) : 407-411 .
-
(2012)
Thorax
, vol.67
, Issue.5
, pp. 407-411
-
-
Richeldi, L.1
Ryerson, C.J.2
Lee, J.S.3
-
24
-
-
0034011982
-
Idiopathic pulmonary fibrosis: Diagnosis and treatment
-
American Thoracic Society,International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)., American Thoracic Society.
-
American Thoracic Society . American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) . Am J Respir Crit Care Med . 2000; 161 (2 pt 1) : 646 - 664 .
-
(2000)
Am J Respir Crit Care Med
, vol.161
, Issue.2 PART 1
, pp. 646-664
-
-
-
25
-
-
84861382039
-
Idiopathic pulmonary fibrosis: Clinically meaningful primary endpoints in phase 3 clinical trials
-
Raghu G, Collard HR, Anstrom KJ, et al . Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials . Am J Respir Crit Care Med . 2012; 185 (10) :1044 - 1048 .
-
(2012)
Am J Respir Crit Care Med
, vol.185
, Issue.10
, pp. 1044-1048
-
-
Raghu, G.1
Collard, H.R.2
Anstrom, K.J.3
-
26
-
-
84865112235
-
Diopathic pulmonary fibrosis: Lung function is a clinically meaningful endpoint for phase III trials
-
du Bois RM, Nathan SD, Richeldi L, Schwarz MI, Noble PW . diopathic pulmonary fibrosis: lung function is a clinically meaningful endpoint for phase III trials . Am J Respir Crit Care Med . 2012; 186 (8) : 712 - 715 .
-
(2012)
Am J Respir Crit Care Med
, vol.186
, Issue.8
, pp. 712-715
-
-
Du Bois, R.M.1
Nathan, S.D.2
Richeldi, L.3
Schwarz, M.I.4
Noble, P.W.5
-
27
-
-
84455168726
-
Forced vital capacity in patients with idiopathic pulmonary fibrosis: Test properties and minimal clinically important difference
-
du Bois RM, Weycker D, Albera C, et al . Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference . Am J Respir Crit Care Med . 2011; 184 (12) : 1382 - 1389 .
-
(2011)
Am J Respir Crit Care Med
, vol.184
, Issue.12
, pp. 1382-1389
-
-
Du Bois, R.M.1
Weycker, D.2
Albera, C.3
-
28
-
-
79955520497
-
Six-minute-walk test in idiopathic pulmonary fibrosis: Test validation and minimal clinically important difference
-
du Bois RM, Weycker D, Albera C, et al . Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference . Am J Respir Crit Care Med . 2011; 183 (9) : 1231 - 1237 .
-
(2011)
Am J Respir Crit Care Med
, vol.183
, Issue.9
, pp. 1231-1237
-
-
Du Bois, R.M.1
Weycker, D.2
Albera, C.3
|